Global Hemostats And Sealants Market Size By Type (Topical Hemostat, Adhesive and Tissue Sealants), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Hemostats and Sealants Market was valued at USD 5.6 billion in 2023 and is projected to reach USD 10.3 billion by 2031, growing at a CAGR of 7.9% during the forecast period from 2023 to 2031. The growth of this market is fueled by rising surgical volumes globally, increasing incidence of traumatic injuries, and the expanding application of hemostatic and sealing agents in minimally invasive surgeries. With technological advancements and the growing focus on reducing surgical complications and operative time, these products are becoming critical components in modern operating rooms.

Drivers

Rising Number of Surgical Procedures:

An increase in both elective and emergency surgical procedures globally, particularly in aging populations and those with chronic diseases, is propelling demand for effective blood management solutions, such as hemostats and sealants.

Advancements in Product Innovation:

Technological improvements, including next-generation combination sealants, bioactive hemostatic agents, and synthetic sealants, are making these products more efficient, easy to use, and compatible with a wide range of surgical applications.

Growing Demand for Minimally Invasive Surgeries:

Minimally invasive procedures demand precise and efficient hemostatic solutions to ensure minimal trauma and quick recovery. Hemostats and sealants are increasingly preferred in laparoscopic and robotic surgeries due to their ability to control bleeding without sutures.

Restraints

High Cost of Advanced Products:

The high cost associated with technologically advanced hemostats and sealants can limit adoption in price-sensitive markets and among smaller healthcare facilities with budget constraints.

Stringent Regulatory Approvals:

Obtaining regulatory clearance for new hemostatic agents is a rigorous and time-consuming process, potentially delaying product launches and impacting market dynamics.

Opportunity

Expansion in Emerging Economies:

Rapid healthcare infrastructure development in regions like Asia-Pacific and Latin America, along with growing awareness of advanced surgical tools, provides a lucrative opportunity for market expansion.

Adoption in Non-traditional Procedures:

Hemostats and sealants are increasingly being utilized in dental, cosmetic, and veterinary surgeries. This expansion of end-use applications can open new revenue streams for manufacturers.

Market by System Type Insights

By system type, the Active Hemostats segment accounted for the largest market share in 2023. These products, which utilize biologically active agents like thrombin and fibrin, are widely preferred for their rapid and effective control of bleeding. Meanwhile, the Combination Hemostats and Sealants segment is projected to register the fastest growth rate, owing to their enhanced efficacy in complex surgical environments where both hemostasis and sealing are needed.

Market by End-use Insights

The Hospitals & Surgical Centers segment emerged as the leading end-user category in 2023, capturing over 65% of the global market. This dominance is attributed to the high volume of surgical procedures performed in hospitals, combined with rising investments in advanced surgical tools and blood loss management solutions. The Ambulatory Surgical Centers (ASCs) segment is expected to witness significant growth due to increasing preference for outpatient surgeries.

Market by Regional Insights

In 2023, North America led the global market, driven by advanced healthcare infrastructure, strong presence of key market players, and high surgical volume. The Asia-Pacific region is anticipated to witness the highest growth during the forecast period, supported by increasing healthcare spending, expansion of medical tourism, and growing penetration of advanced surgical solutions in emerging markets such as India, China, and Southeast Asia.

Competitive Scenario

Leading players in the global Hemostats and Sealants Market include:

Baxter International Inc.

Johnson & Johnson (Ethicon, Inc.)

B. Braun Melsungen AG

Integra LifeSciences

CryoLife, Inc.

CSL Behring

Pfizer Inc.

Medtronic plc

BD (Becton, Dickinson and Company)

Biom’Up SA

These companies are investing in product innovation, clinical research, and strategic acquisitions to strengthen their market positions. For example:

In 2024, Baxter launched an advanced fibrin sealant designed for rapid action in minimally invasive procedures.

In 2023, Ethicon received FDA approval for a next-gen combination hemostat tailored for cardiovascular surgeries.

Scope of Work – Global Hemostats and Sealants Market

Report Metric Details

Market Size (2023) USD 5.6 billion

Projected Market Size (2031) USD 10.3 billion

CAGR (2023–2031) 7.9%

Market Segments By System Type (Active, Passive, Combination), By End-use (Hospitals, ASCs, Specialty Clinics), By Region

Growth Drivers Increasing surgeries, innovation in hemostatic technologies, demand for minimally invasive solutions

Opportunities Emerging market expansion, adoption in dental & cosmetic procedures

Key Market Developments

2024: Baxter introduced a next-generation hemostatic patch with enhanced tissue adhesion properties for trauma applications.

2023: Integra LifeSciences expanded its sealant production facility in Europe to meet rising regional demand.

2022: Ethicon launched a novel sprayable hemostat aimed at laparoscopic procedures, gaining traction among robotic surgery centers.

FAQs

1) What is the current market size of the Hemostats and Sealants Market?

The market was valued at USD 5.6 billion in 2023.

2) What is the major growth driver of the Hemostats and Sealants Market?

Rising surgical volumes and increasing adoption of advanced hemostatic technologies.

3) Which is the largest region during the forecast period in the Hemostats and Sealants Market?

North America held the largest market share in 2023, but Asia-Pacific is expected to grow fastest.

4) Which segment accounted for the largest market share in Hemostats and Sealants Market?

The Hospitals & Surgical Centers segment led the market in 2023.

5) Who are the key market players in the Hemostats and Sealants Market?

Major players include Baxter International, Ethicon (Johnson & Johnson), Medtronic, Integra LifeSciences, and B. Braun.